Skip to main content
. 2007 Sep 17;51(12):4351–4355. doi: 10.1128/AAC.00251-07

FIG. 1.

FIG. 1.

Typical human cumulative AUC0-24 following a 400-mg dose of gatifloxacin (dashed line) and murine cumulative AUC0-24 (solid line) representative of those for mice given a regimen designed to mimic the cumulative exposure in humans.